While counseling and other services are an important part of a comprehensive treatment plan for opioid use disorder, the provision of medication should not be made contingent upon participation in such services, the Food and Drug Administration and Substance Abuse and Mental Health Services Administration told health care providers in guidance intended to clarify buprenorphine prescribing recommendations.
 
“Given the elevated risk of fatal overdose without medication therapy, any difficulty in connecting patients with counseling and/or other behavioral health resources should not prevent practitioners from prescribing buprenorphine for the treatment of OUD,” the guidance states. “Evidence reveals that when counseling or other resources are not immediately available, patients can still benefit from buprenorphine treatment. While counseling should always be offered to patients, this reflects the understanding that engaging people with OUD in treatment is complex and can begin with stabilization on medication. As with any chronic condition, treatment planning should meet people where they are, be supportive, person-centered, and shared.”

Related News Articles

Headline
The Food and Drug Administration Jan. 30 announced it approved Journavx (suzetrigine) oral tablets, a first-in-class non-opioid drug, to treat moderate to…
Headline
In this conversation, Vinnidhy Dave, D.O., hospice specialist and director of palliative medicine at Englewood Health Physician Network, and Lauren Savage,…
Headline
The Substance Abuse and Mental Health Services Administration Jan. 7 announced it will award $1 million grants to 14 states and Washington, D.C., to take part…
Headline
The Centers for Medicare & Medicaid Services today announced Michigan, New York, Oklahoma and South Carolina state Medicaid agencies were selected to…
Headline
In this conversation, Matthew Hoag, director of integrated behavioral health at Denver Health, shares how the organization is innovating through integration to…
Headline
The AHA Oct. 24  announced it has been awarded a nearly $1.5 million grant from the Centers for Disease Control and Prevention as part of its National…